SF3B1 and myelodysplastic syndrome: Recently, the International Working Group for the Prognosis of MDS (IWG-PM) has proposed a modification in the classification of MDS, not defining a subgroup based on the presence of ring sideroblasts, but rather on the presence of the SF3B1 mutation.